3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
16
Phase 1
15
Phase 1/2
6
Phase EARLY_PHASE1
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
26
Leukemia, Lymphocytic, Chronic, B-Cell
16
Myelodysplastic Syndromes
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Non-Hodgkin
6
Lymphoma, Follicular
6
Leukemia
6
Multiple Myeloma
5
Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Graft vs Host Disease
2
Waldenstrom Macroglobulinemia
1
Venentoclax
1
Sarcoma, Synovial
1
Primary Myelofibrosis
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm, Residual
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Biphenotypic, Acute
1
Burkitt Lymphoma
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
Paclitaxel
20
Gemcitabine
16
Dexamethasone
16
Bevacizumab
16
Docetaxel
15
Oxaliplatin
14
Cyclophosphamide
13
Carboplatin
12
Capecitabine
12
Sorafenib
11
Fluorouracil
11
Leucovorin
10
Cisplatin
10
pembrolizumab
9
Pemetrexed
9
Epoetin Alfa
9
venetoclax
8
Prednisone
8
Fentanyl
8
Drug Therapy
8
Doxorubicin
8
atezolizumab
7
Rivaroxaban
7
Rituximab
7
Darbepoetin alfa
7
Anastrozole
7
Panitumumab
6
Ondansetron
6
Morphine
6
Irinotecan
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
fludarabine
×
Clear all
NCT05477589
2024-12-19
SCRIPT-AML
Vastra Gotaland Region
Phase 3
Recruiting
170 enrolled